Quell Therapeutics reposted this
This week our team are in Vancouver for #ISCT2024. Our SVP Research & Product Development Nathalie Belmonte will be giving a presentation tomorrow (31st May) discussing how we are using CAR-Tregs to treat autoimmune diseases. Yesterday, Sim Tung presented a poster on our technology platform, and Aleks Guvenel, shared his insights on a panel re: next gen manufacturing platforms. Great to see our R&D team presenting our science to the global cell therapy community!
Great job guys!
It's wonderful to see your team actively engaging with the global cell therapy community at ISCT2024 in Vancouver. Presenting on CAR-Tregs for autoimmune diseases, sharing insights on technology platforms, and contributing to discussions on manufacturing platforms demonstrates your commitment to advancing the field. Keep up the great work in showcasing your R&D efforts on such important topics.